Literature DB >> 10809943

Coexistence of dominant and recessive familial amyotrophic lateral sclerosis with the D90A Cu,Zn superoxide dismutase mutation within the same country.

J Khoris1, B Moulard, V Briolotti, M Hayer, A Durieux, P Clavelou, A Malafosse, G A Rouleau, W Camu.   

Abstract

The Cu,Zn superoxide dismutase (Cu,Zn SOD) mutations described in amyotrophic lateral sclerosis (ALS) have, for the most part, a dominant influence. However, while a few cases with a heterozygous D90A mutation have been described in different countries, D90A has been recently proven to be recessively inherited with a common founder effect in Scandinavia. We screened French ALS families for Cu,Zn SOD mutations. The presence of the D90A allele was found in two index-cases, and their families were subsequently studied. In the first family the ALS patients were homozygotes for D90A, while in the second, all ALS patients were heterozygotes. In both families the disease was found to initially involve the lower limbs with slower progression than in sporadic cases, and frequent atypical signs such as paresthesia and urgency of micturition. We determined the D90A allele frequency in controls (n = 200) and sporadic ALS patients (n = 408). No D90A allele was found. This is the first report of coexistence of dominant and recessive families with the D90A Cu,Zn SOD mutation within the same country.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809943     DOI: 10.1046/j.1468-1331.2000.00028.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

2.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

3.  Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis.

Authors:  Marco Luigetti; Amelia Conte; Francesca Madia; Giuseppe Marangi; Marcella Zollino; Irene Mancuso; Michele Dileone; Alessandra Del Grande; Vincenzo Di Lazzaro; Pietro Attilio Tonali; Mario Sabatelli
Journal:  Neurol Sci       Date:  2009-08-15       Impact factor: 3.307

4.  SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity.

Authors:  Mariusz Berdyński; Przemysław Miszta; Krzysztof Safranow; Peter M Andersen; Mitsuya Morita; Sławomir Filipek; Cezary Żekanowski; Magdalena Kuźma-Kozakiewicz
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 5.  Human TBK1: A Gatekeeper of Neuroinflammation.

Authors:  Liyana Ahmad; Shen-Ying Zhang; Jean-Laurent Casanova; Vanessa Sancho-Shimizu
Journal:  Trends Mol Med       Date:  2016-06       Impact factor: 15.272

6.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

Review 7.  Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosis.

Authors:  Pierre-François Pradat; Mohamed-Mounir El Mendili
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

8.  Individual Oligogenic Background in p.D91A-SOD1 Amyotrophic Lateral Sclerosis Patients.

Authors:  Giulia Gentile; Benedetta Perrone; Giovanna Morello; Isabella Laura Simone; Sebastiano Andò; Sebastiano Cavallaro; Francesca Luisa Conforti
Journal:  Genes (Basel)       Date:  2021-11-23       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.